Akiko Miyashita

Director/Board Member at

U.S.-Japan Council

Net worth: 2 M $ as of 2026-08-30

70 year

67 connections

Technology Services

Health Technology

Consumer Services

Profile

Akiko Moni Miyashita is currently Director at U.S.-Japan Council, Director at Averin Capital Acquisition Corp.
starting in 2026, and Chief Strategy Officer at Valo Health LLC since 2019.
Former positions include Independent Director at EMI Holding, Inc. from 2014 to 2015, Independent Director at Halozyme Therapeutics, Inc. from 2022 to 2026, Vice President-Corporate Development at International Business Machines Corp.
from 2009 to 2011, Partner at Innosight Consulting LLC from 2011 to 2015, and Trustee at The Children's Hospital of Philadelphia Foundation.
Education includes an MBA from Daniels College of Business and undergraduate studies at The Leeds School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
HALOZYME THERAPEUTICS, INC. 0.02%	2026-03-08	20,772 ( 0.02% )	2 M $	2026-08-30

Akiko Miyashita active positions

Companies	Position	Start
U.S.-Japan Council U.S.-Japan Council Internet Software/ServicesTechnology Services Operates as a platform for events, news and media	Director/Board Member	-
Valo Health LLC Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform	Corporate Officer/Principal	2019-04-30

All active positions of Akiko Miyashita

Former positions of Akiko Miyashita

Companies	Position	End
HALOZYME THERAPEUTICS, INC.	Director/Board Member	2026-05-04
EMI Holding, Inc. EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases	Director/Board Member	2015-04-27
Innosight Consulting LLC Innosight Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting and training services	Corporate Officer/Principal	2014-12-31
IBM	Corporate Officer/Principal	2010-12-31
The Children's Hospital of Philadelphia Foundation The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services	Director/Board Member	-

See the detail of Akiko Miyashita's experience

Training of Akiko Miyashita

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Akiko Miyashita's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
International Business Machines Corp. International Business Machines Corp. Information Technology ServicesTechnology Services Provides software, IT consulting, cloud and infrastructure services	Technology Services
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets	Health Technology
EMI Holding, Inc. EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases	Health Technology
Innosight Consulting LLC Innosight Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides management consulting and training services	Commercial Services
The Children's Hospital of Philadelphia Foundation The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services	Health Services
U.S.-Japan Council U.S.-Japan Council Internet Software/ServicesTechnology Services Operates as a platform for events, news and media	Technology Services
Daniels College of Business Daniels College of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Leeds School of Business The Leeds School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Valo Health LLC Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform	Technology Services